We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
DTE Energy
DTE
$29.1B
| $63.5M | 0.14% |
502,186
-120,279
| -19% | -$15.7M |
|
177
Newmont
NEM
$119B
| $63.2M | 0.14% |
1,059,381
+35,176
| +3% | +$2.49M |
|
178
Penske Automotive Group
PAG
$14.2B
| $62.7M | 0.14% |
602,121
-32,750
| -5% | -$3.51M |
|
179
Church & Dwight Co
CHD
$24.5B
| $62.6M | 0.14% |
675,747
+104,408
| +18% | +$9.86M |
|
180
Synchrony
SYF
$25.6B
| $62.4M | 0.14% |
2,287,032
+1,499,472
| +190% | +$52.1M |
|
181
Genuine Parts
GPC
$18.7B
| $61.7M | 0.14% |
467,793
-106,535
| -19% | -$14.2M |
|
182
Bread Financial
BFH
$4.38B
| $61.7M | 0.14% |
1,682,427
+1,181,346
| +236% | +$60.2M |
|
183
Booking.com
BKNG
$161B
| $61.2M | 0.14% |
891,300
+348,750
| +64% | +$29.8M |
|
184
Alaska Air
ALK
$5.58B
| $60.5M | 0.14% |
1,560,880
+819,223
| +110% | +$40M |
|
185
Eaton
ETN
$174B
| $60.2M | 0.14% |
482,097
-431,453
| -47% | -$60.4M |
|
186
T. Rowe Price
TROW
$24.3B
| $60M | 0.14% |
540,734
-91,744
| -15% | -$11.7M |
|
187
Knight Transportation
KNX
$11.4B
| $59.9M | 0.14% |
1,320,260
+390,933
| +42% | +$18.5M |
|
188
Ally Financial
ALLY
$13.3B
| $59.8M | 0.14% |
1,819,000
+69,126
| +4% | +$2.76M |
|
189
Intuit
INTU
$89B
| $59.5M | 0.13% |
157,371
-66,820
| -30% | -$27.7M |
|
190
Altria Group
MO
$114B
| $59M | 0.13% |
1,417,402
+318,268
| +29% | +$16.5M |
|
191
Waters Corp
WAT
$39.9B
| $58.2M | 0.13% |
177,564
-57,105
| -24% | -$18.1M |
|
192
W.W. Grainger
GWW
$60.2B
| $58.1M | 0.13% |
128,896
-91,812
| -42% | -$44.6M |
|
193
Cadence Design Systems
CDNS
$93.4B
| $58.1M | 0.13% |
389,056
+7,636
| +2% | +$1.15M |
|
194
Lennox International
LII
$15.2B
| $58M | 0.13% |
286,735
-9,962
| -3% | -$2.18M |
|
195
Paychex
PAYX
$42.7B
| $58M | 0.13% |
509,242
-19,465
| -4% | -$2.44M |
|
196
Dow Inc
DOW
$21.2B
| $57.8M | 0.13% |
1,133,768
+417,880
| +58% | +$26.8M |
|
|
SYNH
197
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $57.6M | 0.13% |
803,538
+373,351
| +87% | +$27.3M |
|
198
Fidelity National Financial
FNF
$13.5B
| $57.5M | 0.13% |
1,641,490
+760,095
| +86% | +$29.7M |
|
199
Keurig Dr Pepper
KDP
$40.8B
| $57.3M | 0.13% |
1,627,770
+976,387
| +150% | +$35.4M |
|
200
Universal Health Services
UHS
$10.5B
| $57.2M | 0.13% |
568,870
+453,569
| +393% | +$56.8M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.